Fractyl Announces Completion of $57 Million Series C Investment
November 19, 2015Fractyl has extended their $40M series C investment with $17M of additional funding. New investor Deerfield Management Company, L.P. joined existing investors Mithril, General Catalyst, Bessemer Venture Partners and Domain Associates.
More »
Celator® Pharmaceuticals Receives Allowance of Expanded U.S. Claims on CombiPlex® Technology
November 19, 2015The patent now covers a broader range of delivery vehicles for drug combinations. The expanded claims strengthens company's position for exclusivity and R&D collaborations in anticancer drug combination space.
More »
Zyga Technology Completes $20 Million Financing
November 17, 2015The company intends to use the proceeds to support growing sales and market development efforts as coverage of minimally invasive sacroiliac joint fusion improves in 2016 and beyond.
More »